I am excited about the Lead clinical trial, due this month. 2RT is world-first preventive laser and in fact the first preventive method to early AMD. We are on the cusp of advancing ophthalmology.
On the side note, I am even more excited about the iTrack in the current state. You can really see the potential advantage of iTrack over other treatment such as iStent, in terms of invasiveness (whether this procedure can be repeated) and its benefit.
Refer to the video for animation of the different treatment:
iTrack:
iStent:
CyPass:
XENGel Stent:
More info on the competitive landscape in Ophthalmic Surgical Product Market
https://medtech.pharmaintelligence....st-Growth-Spot-In-Eye-Surgery-Products-Market
2RT LEAD results June 2018, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.48M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.0¢ | 22.5¢ | $56.9K | 251.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 347271 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 92120 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |